SS Innovations Files 10-Q/A Amendment

Ticker: SSII · Form: 10-Q/A · Filed: Apr 1, 2025 · CIK: 1676163

Sentiment: neutral

Topics: amendment, 10-Q, filing-update

TL;DR

SS Innovations filed an amendment to its Q3 2024 10-Q. Check for updates.

AI Summary

SS Innovations International, Inc. filed an amendment (Amendment No. 1) to its Form 10-Q for the quarterly period ended September 30, 2024. The filing, dated April 1, 2025, provides updated information for the company, formerly known as AVRA Medical Robotics, Inc. The company is incorporated in Florida and its principal executive offices are located in Gurugram, Haryana, India.

Why It Matters

This filing provides updated financial and operational information for SS Innovations International, Inc., which is crucial for investors to assess the company's performance and make informed decisions.

Risk Assessment

Risk Level: low — This is a routine amendment to a quarterly report, not indicating new or significant negative developments.

Key Players & Entities

FAQ

What is the purpose of this filing?

This filing is Amendment No. 1 to the Form 10-Q for the quarterly period ended September 30, 2024, for SS Innovations International, Inc.

What was the previous name of SS Innovations International, Inc.?

The former company name was AVRA Medical Robotics, Inc., with a date of name change on June 1, 2016.

In which state is SS Innovations International, Inc. incorporated?

The company is incorporated in Florida.

Where are the principal executive offices of SS Innovations International, Inc. located?

The principal executive offices are located at 405, 3rd Floor, iLabs Info Technology Centre, Udyog Vihar, Phase III, Gurugram, Haryana 122016, India.

What is the SEC file number for SS Innovations International, Inc.?

The SEC file number is 333-216054.

Filing Details

This Form 10-Q/A (Form 10-Q/A) was filed with the SEC on April 1, 2025 regarding SS Innovations International, Inc. (SSII).

View full filing on EDGAR

View Full Filing

View this 10-Q/A filing on SEC EDGAR

View on Read The Filing